Health Care Sector News

Latest News

  • Express Scripts excludes 20 more drugs from 2016 coverage Reuters - UK Focus - Fri, Jul 31, 2015 21:24 BST

    Express Scripts Holding Corp , the largest U.S. pharmacy benefit manager, said on Friday that it would exclude about 20 new medications in 2016 from insurance coverage, including two diabetes drugs and a weight loss drug. For the past several years, Express Scripts has been excluding medicines from its coverage list, a …

  • After Merck success, work goes on with other Ebola vaccines Reuters - UK Focus - Fri, Jul 31, 2015 16:29 BST

    Scientists and drug companies will continue to research the potential of alternative Ebola vaccines, despite a shot from Merck (Other OTC: MKGAF - news) and NewLink Genetics (Berlin: 4NX.BE - news) proving 100 percent effective in a trial in Guinea. Experts said on Friday different kinds of vaccines were needed that …

  • Form 8.3 - Synergy Health Plc Business Wire - Fri, Jul 31, 2015 15:11 BST

    LONDON--(BUSINESSWIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) ...

  • Airbus Group interested in boosting MBDA stake Reuters - UK Focus - Fri, Jul 31, 2015 12:04 BST

    European missile maker MBDA moved closer towards a reshuffle of ownership on Friday as Airbus Group signalled interest in expanding its share, while Italy's Finmeccanica said it would be open to selling ...

  • GlaxoSmithKline plc (LON:GSK) is less likely to deliver higher returns than Hikma Pharmaceuticals Plc (LON:HIK) over the medium term, argues Alessandro Pasetti.

  • London open: Shares open slightly higher ahead of US data Sharecast - Fri, Jul 31, 2015 10:20 BST

    (ShareCast News) - The FTSE 100 opened indecisively as investors sifted through earnings and looked ahead to US data releases.

  • Australia shares up for 3rd day, financials rise; China a risk factor Reuters - UK Focus - Fri, Jul 31, 2015 04:44 BST

    SYDNEY/WELLINGTON, July 31 (Reuters) - Australian shares rose for the third straight day on Friday, as investors bought into higher yielding financial sector stocks and kept a wary eye over volatile markets in China. Everything that could go wrong, went wrong," said Mathan Somasundaram, quantitative strategist at Baillieu …

  • London midday: FTSE in the red on mixed earnings, data Sharecast - Fri, Jul 31, 2015 01:20 BST

    (ShareCast News) - The FTSE 100 slipped into the red on the back of a flat session in Asian markets, mixed earnings releases and economic data.

  • Amgen profit tops Street view, boosts full-year forecast Reuters - Thu, Jul 30, 2015 21:51 BST
    An Amgen sign is seen at the company's office in South San Francisco

    Excluding special items, Amgen earned $2.57 per share, topping analysts' average expectations by 14 cents, according to Thomson Reuters I/B/E/S. The strong second-quarter performance led the world's largest biotechnology company to boost 2015 profit and revenue expectations. Amgen now sees adjusted earnings of $9.55 to …

  • HellermannTyton surges on Delphi Automotive takeover Telegraph - Thu, Jul 30, 2015 19:13 BST

    Shares in HellermannTyton posted their biggest ever one-day jump after Delphi Automotive said it would buy the company.

  • London close: Stocks end higher despite Fed decision Sharecast - Thu, Jul 30, 2015 18:32 BST

    (ShareCast News) - London share prices ended modestly higher despite the US Federal Reserve's decision to leave the door open to possible interest rate increases in September which, it must be pointed ...

  • (ShareCast News) - London's top-flight index was up 0.6% at 6,670 by 15:41 BST, as investors waded through a raft of earnings reports.

  • Cigna CEO David Cordani is interviewed at Reuters Health Summit 2014 in Washington

    Health insurers have benefited from low medical services use during the past five years as the weak economy has kept down doctor visits and hospitalizations and membership growth has helped increase revenues. The national healthcare reform law, also known as Obamacare, has contributed to the increase as millions of people …

  • Royston Wild looks at the investment case for GlaxoSmithKline plc (LON: GSK), Bodycote PLC (LON: BOY) and RPS Group plc (LON: RPS).

  • Reuters Business News Schedule at 1230 GMT/0830 AM ET Reuters - UK Focus - Thu, Jul 30, 2015 13:38 BST

    Editor: Sonya Hepinstall +44 207 542 3479 Global Picture Desk: +65 6870 3775 Global Graphics Desk: +65 6870 3595 Receive this schedule by email: http://mediaexpress.reuters.com TOP STORIES U.S. 2nd-quarter ...

  • Should you add these 2 stocks to your portfolio? AstraZeneca plc (LON: AZN) and Countrywide PLC (LON: CWD)

  • (ShareCast News) - London's top flight index was holding on to slight gains at the start of the session, as analysts continued to debate the the US central bank's policy statement issued last night.

  • (ShareCast News) - AstraZeneca's second-quarter earnings beat expectations as generic competition and the effects of a stronger US dollar were offset by the spinning off of assets and a good performance ...

  • Astrazeneca's blood thinning drug helps beat City estimates Telegraph - Thu, Jul 30, 2015 10:33 BST

    UK's second largest drugmaker beats analyst estimates as blood thinner Brilinta helps offset the falls in its older medicines

  • (ShareCast News) - European stocks were little changed, paring early gains as investors weighed up disappointing German labour data against a torrent of mostly well-received earnings reports.

  • Reuters Business News Schedule at 0830 GMT/0430 AM ET Reuters - UK Focus - Thu, Jul 30, 2015 09:59 BST

    Editor: Sonya Hepinstall +44 207 542 3479 Global Picture Desk: +65 6870 3775 Global Graphics Desk: +65 6870 3595 Receive this schedule by email: http://mediaexpress.reuters.com TOP STORIES Shell to axe ...

  • AstraZeneca beats profit forecasts, helped by external deals Reuters - UK Focus - Thu, Jul 30, 2015 08:55 BST

    AstraZeneca (NYSE: AZN - news) revenue fell by a smaller-than-expected 7 percent in the second quarter, as income from selling rights to medicines offset generic competition to older drugs and a strong dollar. The drugmaker increased its revenue forecast for the year and said it now expected a low single-digit percentage …

  • BUZZ-AstraZeneca: EPS, sales beat to help shares up a 2nd day Reuters - UK Focus - Thu, Jul 30, 2015 07:53 BST

    ** AstraZeneca L>, one of Europe's worst performing healthcare stocks this year, seen opening as much as 3 pct higher following a better-than-expected Q2 ** Co raised its rev forecast for the year, ...

  • London midday: Heavyweight corporate earnings lift FTSE 100 Sharecast - Thu, Jul 30, 2015 01:17 BST

    (ShareCast News) - London share prices remained mostly in positive territory by midday on Thursday, as strong corporate results from heavyweights in various sectors, notably Shell, RBS and Astrazeneca, ...

  • The office building of health insurer Anthem is seen in Los Angeles, California

    Health insurer Anthem Inc , which plans to buy rival Cigna Corp for $47 billion, on Wednesday said medical costs, particularly in its Medicaid and Medicare businesses, were at the low end of expectations ...

  • GlaxoSmithKline sees staged roll-out of malaria vaccine Reuters - UK Focus - Wed, Jul 29, 2015 19:33 BST

    The world's first malaria vaccine, which won a green light last week from European drugs regulators, will be rolled out gradually in Africa, its maker said on Wednesday. "We believe that there should be a thoughtful, staged roll-out of this vaccine, particularly because it is important that we acquire more knowledge about …

  • S.Africa's Union Resources bids around $136 mln for Amplats mine-source Reuters - UK Focus - Wed, Jul 29, 2015 18:43 BST

    A group of South African investors known as Union Resources has offered around 1.7 billion rand ($136 million) for Anglo American Platinum's Union mine, a source with direct knowledge of the matter said, slashing the bid from about 3 billion rand after due diligence. Tshepo Bokaba, chairman of Union Resources which was …

  • London close: Defensives lead gains ahead of Fed meeting Sharecast - Wed, Jul 29, 2015 18:30 BST

    (ShareCast News) - Equity markets bounced back ahead of the policy announcement due out from the US Federal Reserve later on Wednesday, as investors waited for more clarity from the central bank before ...

  • FTSE 100 movers: GSK and Hikma lead blue chips higher Sharecast - Wed, Jul 29, 2015 17:00 BST

    (ShareCast News) - The FTSE 100 index built an early lead on Wednesday and stayed in positive territory thanks to forecast-busting results from several heavyweights in the pharma, tobacco and banking sectors....

  • FTSE finishes higher, Hikma and GlaxoSmithKline boost Reuters - UK Focus - Wed, Jul 29, 2015 16:54 BST

    Britain's top share index advanced on Wednesday, with Hikma Pharmaceuticals leading the market higher on positive broker comments and GlaxoSmithKline gaining after reporting a lower-than-expected fall ...

  • S.Africa's Union Resources among bidders for Amplats mine Reuters - UK Focus - Wed, Jul 29, 2015 15:47 BST

    A group of South African investors known as Union Resources has made a bid for Anglo American Platinum's Union mine, its chairman said on Wednesday. Union Resources chairman Tshepo Bokaba said the group was bidding for the mine, but declined to say how much his company was offering. Anglo American Platinum or Amplats, …

  • GSK beats expectations as anti-HIV drugs lift sales Telegraph - Wed, Jul 29, 2015 15:09 BST

    Results are the first since the blue-chip business completed a swap with peer Novartis

  • GSK beats expectations with second-quarter results Telegraph - Wed, Jul 29, 2015 15:09 BST

    Strong revenues from anti-HIV and new asthma drugs means GSK delivers better than forecast perfomance

  • FTSE extends gains, Hikma and GlaxoSmithKline support Reuters - UK Focus - Wed, Jul 29, 2015 15:06 BST

    Britain's top share index advanced on Wednesday, with Hikma Pharmaceuticals leading the market higher on positive broker comments and GlaxoSmithKline gaining after reporting a lower-than-expected fall ...

  • GSK flags up pipeline as HIV drugs help it beat profit forecasts Reuters - UK Focus - Wed, Jul 29, 2015 14:04 BST

    GlaxoSmithKline (Other OTC: GLAXF - news) moved to reclaim its prowess as a research powerhouse on Wednesday by flagging up dozens of new drugs and vaccines in development, as demand for new HIV medicines helped it beat quarterly profit forecasts. Strong sales of Tivicay and Triumeq validated GSK's decision in May to …

Next >>